We are live on
!
Find out more
RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
114 hedge funds and large institutions have $564M invested in Revance Therapeutics, Inc. in 2019 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 43 increasing their positions, 25 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
72% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 25
24% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 17
2% more funds holding
Funds holding: 112 → 114 (+2)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
14% less capital invested
Capital invested by funds: $656M → $564M (-$92.4M)
49% less call options, than puts
Call options by funds: $740K | Put options by funds: $1.46M
Holders
114
Holders Change
+2
Holders Change %
+1.79%
% of All Funds
2.48%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
21
Increased
43
Reduced
25
Closed
17
Calls
$740K
Puts
$1.46M
Net Calls
-$722K
Net Calls Change
-$919K
Top Buyers
Top Sellers
| 1 |
JP Morgan Chase
New York
|
-$17.9M |
| 2 |
Morgan Stanley
New York
|
-$1.29M |
| 3 |
Two Sigma Investments
New York
|
-$1.02M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$796K |
| 5 |
Goldman Sachs
New York
|
-$741K |
